K Pharma (TSE:4896) Long-Term Debt: 円1,500.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4896 K Pharma Inc TSE:4896
12 GF Score
Price 円750.00
! 1 Warning Sign
View Full Analysis

What is K Pharma Long-Term Debt?

K Pharma TSE:4896 -3.85% 12 Long-Term Debt is 円1,500.00 Mil as of Dec. 2025. GuruFocus rates TSE:4896 with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

K Pharma's Long-Term Debt for the quarter that ended in Dec. 2025 was 円1,500.00 Mil.

K Pharma's quarterly Long-Term Debt stayed the same from Jun. 2025 (円0.00 Mil) to Sep. 2025 (円0.00 Mil) but then increased from Sep. 2025 (円0.00 Mil) to Dec. 2025 (円1,500.00 Mil).

K Pharma's annual Long-Term Debt stayed the same from Dec. 2023 (円0.00 Mil) to Dec. 2024 (円0.00 Mil) but then increased from Dec. 2024 (円0.00 Mil) to Dec. 2025 (円1,500.00 Mil).

K Pharma  (TSE:4896) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

K Pharma Long-Term Debt Related Terms

K Pharma Long-Term Debt Historical Data

* Premium members only.

The historical data trend for K Pharma's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

K Pharma Long-Term Debt Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
0.00 0.00 0.00 0.00 1,500.00

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 1,500.00 1,600.00
TSE:4896
12GF Score
K Pharma Inc TSE:4896
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of 円1,500.00 Mil mean?
K Pharma (TSE:4896) has a Long-Term Debt of 円1,500.00 Mil as of Dec. 2025.
Is K Pharma's Long-Term Debt too high?
K Pharma's current Long-Term Debt is 円1,500.00 Mil. Overall, K Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does K Pharma's Long-Term Debt compare to VRTX and REGN?
K Pharma's Long-Term Debt of 円1,500.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. K Pharma's current Long-Term Debt is 円1,500.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is K Pharma stock overvalued right now?
K Pharma (TSE:4896) has a current Long-Term Debt of 円1,500.00 Mil. The current Long-Term Debt is 円1,500.00 Mil. K Pharma's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For K Pharma (TSE:4896), the current Long-Term Debt is 円1,500.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

K Pharma Business Description

Address 7-7-7 Roppongi, Tri-Seven Roppongi 8th Floor, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales, and marketing of pharmaceutical products and regenerative medicine products. It is involved in the study of iPs cells in regenerative medicine to treat neurological conditions such as cerebral infarction and SCI.
12GF Score

Get the complete analysis for TSE:4896

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円750.00
Price